Alpha Ivf Group Berhad (Malaysia)

The Company was incorporated in Malaysia on 10 February 2021 as a private limited company under the name of Alpha IVF Group Sdn Bhd and was subsequently converted to a public limited company on 21 August 2023 under our present name Alpha IVF Group Berhad.
The Company s principal activity is investment holding. Through our subsidiaries, the company are primarily a fertility care specialist focusing on the provision of assisted reproductive services in Malaysia and Singapore.
2011 - Incorporation of Alpha KL on 30 March 2011. The company commenced operations in the same year through the opening of Alpha Fertility Centre, our first specialist centre located at Dataran Sunway in Selangor which has an operational floor area of approximately 7,307 sq. ft. The company started offering a range of assisted reproductive services including IVF, IUI, ICSI as well as cryopreservation for the storage of eggs, sperm and embryos. In addition, the company started providing obstetrics and gynaecology services. As part of our range of services, the company introduced preimplantation genetic diagnosis (PGD) and screening (PGS) (now known as preimplantation genetic testing (PGT) that covers both PGD and PGS) to detect embryo chromosomal abnormalities. The intention is to select embryos with the normal number of chromosomes as well as to detect the existence of defective genes and wrong positioning of segments of chromosomes.
2013 - The company started using a third-party proprietary technology and equipment developed in Japan, namely Cryotec for eggs and embryo cryopreservation, storage and thawing. This cryopreservation method uses a vitrification method which enables living cells to be cooled in the absence of ice formation to safely cryopreserve and thaw cellular living organisms. The company also started to offer the Piezo-intracytoplasmic sperm injection technology (Piezo- ICSI) which is a technique which uses a finer and blunt injection tip to assist in the injection of a sperm into the nucleus of the egg.
2014 - The company started offering a third-party sperm sorting technology which separates a sperm sample into one group containing sperm with higher chances of carrying the Xchromosome, and another group containing sperm with higher chances of carrying the Ychromosome. This microsorting service is carried out by external laboratories. The company started offering a time-lapse embryo imaging system which is a system comprising cameras and computer software to observe the progress of embryo development. The time-lapse embryo imaging system is then integrated to our incubator where the images of the embryo are captured at regular intervals while it is developing in the incubator. As such, embryo development is assessed and observed on a time-lapse basis. This allows the embryologist to select the best embryos for transfer based on cell division patterns on a time-series basis.
2015 - As part of our PGT procedures, the company started using a new technology namely nextgeneration sequencing (NGS), to screen all 46 chromosomes in developing embryos and to identify embryos with monogenic (specific) diseases and chromosomal abnormalities.
2016 - The company marketed our assisted reproductive services in foreign countries and started to serve patients from China in our specialist centre in Dataran Sunway, Selangor.
2017 - The company started offering a time-lapse embryo imaging system with built-in incubator to observe the progress of embryo development.
2019 - Through our subsidiary, Alpha Singapore, the company expanded to Singapore where we opened a specialist centre at the Royal Square at Novena which has an operational floor area of approximately 5,297 sq. ft. During the same year, the company obtained a Reproductive Technology Accreditation Committee (RTAC) certification from the Fertility Society of Australia (FSA) for our Singapore centre. RTAC certification is a requirement for the operations of assisted reproductive services in Singapore. The RTAC certification verifies that Alpha Singapore meets the requirement of the FSA code of practices where the criteria assessed include quality management system, stakeholder feedback, medical management, availability of information to patients, medication management and emergency care.
2020 - The company moved to our current premises located at The Strand Mall in Selangor which has an operational floor area of approximately 26,221 sq. ft. The company obtained Reproductive Technology Accreditation Committee (RTAC) certification from the Fertility Society of Australia (FSA) for Alpha KL. The RTAC certification verifies that Alpha KL meets the requirement of the FSA code of practices as discussed above. RTAC certification is not a requirement for the operations of assisted reproductive services in Malaysia. The company started to offer ovarian rejuvenation treatment with platelet-rich plasma (Ova-PRP) for our patients, where the patient's own (autologous) PRP is injected into the patient's ovaries. This treatment is intended to rejuvenate the ovarian tissue, improve oxygen and nutrient supply to reactivate dormant eggs to develop and mature within the ovaries. At present PRP procedures are not standard procedures for assisted reproductive services. The company started using Artificial Intelligence (AI) enhanced embryo selection technology to identify the best embryos among a group of embryos for transfer. In the same year, we achieved our first successful pregnancy using AI-enhanced embryo selection technology
2021 - The company started to use PRP for the treatment of patients with thin endometria (Endo-PRP), where the infusion of PRP into the uterus wall lining is intended to improve the thickness of the endometrium (uterus wall lining) to help with the implantation of embryos into the uterus wall lining. At present PRP procedures are not standard procedures for assisted reproductive services. The company expanded to the northern region of Peninsular Malaysia through the acquisition of Genesis which has an operational floor area of approximately 11,931 sq. ft. located in Gurney Mall in Penang.
2022 - Our Penang specialist centre obtained ISO 9001: 2015 quality management system for providing a range of fertility and gynae treatment, which was certified by QAS International Limited and valid up to July 2024.
The World Health Organisation declared Covid-19 a pandemic on 11 March 2020. The Government of Malaysia implemented several measures to reduce and control the spread of COVID-19 in the country, commencing on 18 March 2020. These measures include restrictions on the movement of people within Malaysia and internationally, and restrictions on business, government, educational, cultural, recreational and other activities.
For our operations in Malaysia, our business is categorised as essential services, and thus the company were able to continue operations during the MCO 1.0 period. The company had implemented measures for our business operations in response to the COVID-19 pandemic to safeguard and protect our customers and employees. During the various phases of the MCO including CMCO, RMCO, FMCO, EMCO, and NRP, and the “Transition to Endemic” phase, the company continued to operate according to the specified guidelines and SOPs, including specified workforce capacity during the respective periods.
Similarly for our Singapore operations, our business was classified under the essential sector, and consequently, the company were allowed to continue our business operations during the circuit breaker lockdown period. The company have implemented measures for our business operations in response to the COVID-19 pandemic to safeguard and protect our customers and employees.